Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoTrav as Replacement Therapy for Uncontrolled Glaucoma on Bimatoprost/Timolol
NCT01230736Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Oct 2010
- Primary completion
- Feb 2011
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of travoprost in Open-angle glaucoma (OAG), ocular hypertension, pigmentary glaucoma (PG), sponsored by Alcon Inc.. Started Oct 2010; status: completed.
02
Drugs
travoprost
03
Conditions
Open-angle glaucoma (OAG)ocular hypertensionpigmentary glaucoma (PG)
Beyond the preview
Go deeper on NCT01230736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01230736.